Compare ATAI & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATAI | LPAA |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 299.3M |
| IPO Year | 2021 | 2024 |
| Metric | ATAI | LPAA |
|---|---|---|
| Price | $4.24 | $10.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 40.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $3,018,000.00 | N/A |
| Revenue This Year | $943.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.64 |
| Revenue Growth | ★ 811.78 | N/A |
| 52 Week Low | $1.15 | $10.01 |
| 52 Week High | $6.75 | $10.70 |
| Indicator | ATAI | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 70.32 |
| Support Level | $4.25 | $10.52 |
| Resistance Level | $4.63 | $10.59 |
| Average True Range (ATR) | 0.21 | 0.01 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 59.04 | 100.00 |
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
Launch One Acquisition Corp is a blank check company.